Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
13/06/2025 09:35
Jun 13 (Reuters) - Jacobson Pharma Corporation FY revenue HKD 1,576.9 million. FY adjusted EBITDA HKD 572.8 million FY net income attributable HKD 300.8 million Final cash dividend HK5.50 cents per share Special cash dividend of HK6.00 cents per share
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group